|
🐜
|
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
39 auth.
Y. Nakamura,
H. Taniguchi,
M. Ikeda,
H. Bando,
Ken Kato,
C. Morizane,
T. Esaki,
Y. Komatsu,
Y. Kawamoto,
N. Takahashi,
M. Ueno,
Y. Kagawa,
T. Nishina,
Takeshi Kato,
Yoshiyuki Yamamoto,
...
J. Furuse,
T. Denda,
H. Kawakami,
E. Oki,
T. Nakajima,
N. Nishida,
K. Yamaguchi,
H. Yasui,
M. Goto,
N. Matsuhashi,
K. Ohtsubo,
K. Yamazaki,
A. Tsuji,
W. Okamoto,
K. Tsuchihara,
T. Yamanaka,
I. Miki,
Y. Sakamoto,
H. Ichiki,
Masayuki Hata,
R. Yamashita,
A. Ohtsu,
J. Odegaard,
T. Yoshino
|
7 |
2020 |
7
🐜
|
|
🐜
|
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
22 auth.
D. Kotani,
E. Oki,
Y. Nakamura,
H. Yukami,
S. Mishima,
H. Bando,
H. Shirasu,
K. Yamazaki,
J. Watanabe,
M. Kotaka,
...
K. Hirata,
N. Akazawa,
K. Kataoka,
Shruti Sharma,
Vasily N Aushev,
A. Aleshin,
T. Misumi,
H. Taniguchi,
I. Takemasa,
T. Kato,
Masaki Mori,
T. Yoshino
|
7 |
2023 |
7
🐜
|
|
🐜
|
Deregulation of the Akt pathway in human cancer.
7 auth.
E. Tokunaga,
E. Oki,
A. Egashira,
N. Sadanaga,
M. Morita,
Y. Kakeji,
...
Y. Maehara
|
7 |
2008 |
7
🐜
|
|
🐜
|
Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection
8 auth.
R. Tokunaga,
Y. Sakamoto,
S. Nakagawa,
Y. Miyamoto,
N. Yoshida,
E. Oki,
...
Masayuki Watanabe,
H. Baba
|
7 |
2015 |
7
🐜
|
|
🐜
|
Activation of PI3K/Akt signaling and hormone resistance in breast cancer
10 auth.
E. Tokunaga,
Y. Kimura,
K. Mashino,
E. Oki,
A. Kataoka,
S. Ohno,
...
M. Morita,
Y. Kakeji,
H. Baba,
Y. Maehara
|
7 |
2006 |
7
🐜
|
|
🦁
|
Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer
11 auth.
E. Oki,
H. Baba,
E. Tokunaga,
Toshihiko Nakamura,
N. Ueda,
Motonori Futatsugi,
...
Kohjiro Mashino,
Manabu Yamamoto,
M. Ikebe,
Y. Kakeji,
Y. Maehara
|
7 |
2005 |
7
🦁
|
|
🐜
|
Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
22 auth.
T. Ishimoto,
K. Miyake,
T. Nandi,
M. Yashiro,
N. Onishi,
K. Huang,
S. Lin,
Ramnarayanan Kalpana,
S. Tay,
Yuka Suzuki,
...
B. Cho,
D. Kuroda,
K. Arima,
Daisuke Izumi,
M. Iwatsuki,
Y. Baba,
E. Oki,
Masayuki Watanabe,
H. Saya,
K. Hirakawa,
H. Baba,
P. Tan
|
7 |
2017 |
7
🐜
|
|
🐜
|
Akt is frequently activated in HER2/neu‐positive breast cancers and associated with poor prognosis among hormone‐treated patients
11 auth.
E. Tokunaga,
Y. Kimura,
E. Oki,
N. Ueda,
Motonori Futatsugi,
K. Mashino,
...
Manabu Yamamoto,
M. Ikebe,
Y. Kakeji,
H. Baba,
Y. Maehara
|
7 |
2006 |
7
🐜
|
|
🐜
|
Overexpression of the MTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis
8 auth.
Y. Toh,
E. Oki,
S. Oda,
E. Tokunaga,
S. Ohno,
Y. Maehara,
...
G. Nicolson,
K. Sugimachi
|
7 |
1997 |
7
🐜
|
|
🐜
|
Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute.
9 auth.
M. Morita,
Rintaro Yoshida,
K. Ikeda,
A. Egashira,
E. Oki,
N. Sadanaga,
...
Y. Kakeji,
T. Yamanaka,
Y. Maehara
|
7 |
2008 |
7
🐜
|
|
🐜
|
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
21 auth.
T. André,
J. Meyerhardt,
T. Iveson,
A. Sobrero,
T. Yoshino,
I. Souglakos,
A. Grothey,
D. Niedzwiecki,
M. Saunders,
R. Labianca,
...
T. Yamanaka,
I. Boukovinas,
D. Vernerey,
J. Meyers,
A. Harkin,
V. Torri,
E. Oki,
V. Georgoulias,
J. Taieb,
A. Shields,
Q. Shi
|
7 |
2020 |
7
🐜
|
